About Insception
Insception is a company based in Mississauga (Canada) founded in 1996 was acquired by Generate in June 2021. Insception operates in a competitive market with competitors including GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.
- Headquarter Mississauga, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$4.5 M (USD), Debt – Venture
Sep 28, 2012
-
Investors
Wellington Financial
& 3 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Insception
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Venture — $4.5M
-
First Round
First Round
(10 Oct 2006)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2012 | Amount | Debt – Venture - Insception | Valuation |
investors |
|
| Oct, 2006 | Amount | Debt – Venture - Insception | Valuation |
investors |
Investors in Insception
Insception has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Wellington Financial, Generate and MMV Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech-focused Venture debt provider investing primarily in the US and Canada
|
Founded Year | Domain | Location | |
|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America
|
Founded Year | Domain | Location | |
|
Private equity fund that buys shares and helps grow owner-managed businesses.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Insception
Financial Statements - Insception
Insception Comparisons
Competitors of Insception
Insception operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Provider of a biorepository of human clinical specimens
|
|
| domain | founded_year | HQ Location |
Biospecimens are collected, preserved, and analyzed for oncology services.
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
|
| domain | founded_year | HQ Location |
Provides bio repository services
|
|
| domain | founded_year | HQ Location |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
Frequently Asked Questions about Insception
Insception was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Insception is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Insception was founded in 1996 and is based in Mississauga, Canada, within the healthcare sector focused on cord blood banking. Over 39,000 units have been collected, processed, and stored through partnerships with facilities like Mount Sinai Hospital and Scarborough Hospital. Ownership is held by Argosy Partners, Mount Sinai Hospital, management, and scientific founders. Services include secure processing, long-term storage, and governance for Canadian families.
Insception's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Insception has 4 investors. Key investors include Wellington Financial, Generate, MMV Financial, and The Succession Fund.